John Link, M.D. and Lisa Curcio, M.D. on Breast Cancer Gene Testing

Interested in learning more about how breast cancer gene testing is helping breast oncologists understand and treat breast cancer? The OC Register quoted Drs. John Link and Lisa Curcio in an article about genomic testing published today.

We encourage you to visit the OC Register’s website to read the entire article. The following passages are from the piece entitled “Breast cancer tests spawn marketing war.”

“They’re very competitive. There’s a war going on in the marketplace,” says John Link, medical director of Breastlink in Orange and author of “The Breast Cancer Survival Manual.”

Lisa D. Curcio, a surgical breast oncologist in Laguna Hills, said, “Recently I am using Mammaprint more,” along with a complementary test by the company, “because it is giving me more information I can use in my treatment decisions.”

Link, the Orange-based oncologist, says that thanks to both Mammaprint and Oncotype, he is using significantly less chemo than he did eight years ago. These new tests have made a major difference in practice,” he says. “Both have been a huge boon.”